Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is it safe to use lipitor and antihistamines together?Does cosentyx work for all psoriasis types?Is there a timeline for lipitor's impact on flexibility?Does grapefruit oil reduce lipitor's cholesterol lowering effect?Does consuming iron rich plants impact lipitor's efficacy?
See the DrugPatentWatch profile for aimovig
What you need to know about Aimovig's migraine treatment Aimovig is a prescription medication used to treat migraines, but it has a unique delivery method. [1] According to the prescribing information for Aimovig, it is administered via a prefilled syringe. Monthly injections for migraine relief Aimovig's dosing instructions call for injections taken once a month. This means patients receive a set of four injections once every 28 days, which can provide up to 3 months of migraine relief. [2] How do these monthly injections work? These injections deliver erenumab (the active ingredient in Aimovig) directly into the subcutaneous tissue (beneath the skin), where it can effectively target and block the activity of calcitonin gene-related peptide (CGRP) receptors. This receptor blockage is believed to inhibit the initiation and frequency of migraine attacks. What happens if I miss a dose? Missing a dose may affect the duration of Aimovig's effectiveness, so patients should consult their healthcare provider if they miss an injection. It's essential to understand that Aimovig's long-term effectiveness can depend on consistent monthly dosing. Why was Aimovig created? The development of Aimovig was driven by the need for more effective and convenient migraine treatments. [3] By addressing the underlying mechanisms of migraines, Aimovig provides relief for those who experience debilitating headaches. Pricing and availability Prices for Aimovig vary depending on location, insurance coverage, and healthcare provider. Please consult your healthcare provider or a pharmacist for more information on pricing and availability. Regulatory and patent information Aimovig has been approved by the US FDA and is manufactured by Amgen. The exclusivity period for Aimovig is currently subject to change based on various regulatory factors. Sources: [1] Amgen's prescription medication information for Aimovig [2] Aimovig prescribing information from Amgen [3] Amgen's research and development statement on Aimovig DrugPatentWatch.com provides comprehensive information on patent expiration and availability for various medications, including Aimovig.
Other Questions About Aimovig :